1-Fluoro-2-(propan-2-yloxy)-4-(trifluoromethyl)benzene, 98%, 10g

(S)-4-methylthiazolidine-2-thione, 10g

5-[1-(3-Hydroxy-phenyl)-meth-(Z)-ylidene]-2-thioxo-imidazolidin-4-one, 95.0%, 500mg

(R)-3-Amino-3-phenylpropionic Acid>98.0%(HPLC)(T)1g

METHYL 5-(BROMOMETHYL)-2-METHOXYBENZOATE, 95.0%, 5g

5-Bromo-4,6-dichloropyrimidine, 96.0%, 10g

4-(3-Bromobenzyl)morpholine, 95+%, 100mg

3-Amino-2-bromophenol, 95.0%, 5g

1-Iodo-3-phenylpropane, 97%, 5g

1H-PYRAZOLO[4,3-C]PYRIDINE, 3-BROMO-4-CHLORO-, 95%, 5g

2-Amino-3-hydroxybenzaldehyde, 97%, 250mg

2-(5-(Trifluoromethyl)pyridin-2-yl)acetic acid, 95.0%, 100mg

Monohidrato de oxalato dipotásico, mínimo 98,5 %, pa, ACS, 500 g, envase de plástico.